← Back
$TERN All transactions

Terns Pharmaceuticals, Inc.

A

$ Value

$0

Shares

1,697

Price

$0

Filed

Feb 2

Insider

Name

Azelby Robert

Title

CIK

0001656998

Roles

Director

Transaction Details

Transaction Date

2026-02-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,697

Footnotes

This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $45,000 for 2026. | The option will vest as to 1/12th of the total shares subject thereto on each monthly anniversary measured from January 1, 2026, such that 100% of the shares subject to the option will be fully vested on January 1, 2027.

Filing Info

Accession No.

0001656998-26-000002

Form Type

4

Issuer CIK

0001831363

Azelby Robert's History

Date Ticker Type Value
2026-02-01 TERN A $0
2025-11-05 CAH A $0
2025-06-13 ADCT F $45K
2025-06-03 ADCT A $0

Other Insiders at TERN (90d)

Insider Bought Sold Last
FELLOWS DAVID A 2026-02-01
KINDLER JEFFREY B 2026-02-01
Turner Heather D 2026-02-01
Tripuraneni Radhika 2026-02-01
Quigley Jill M. 2026-02-01
Burroughs Amy L.
Chief Executive Officer
$572K 2026-02-17
Kuriakose Emil
Chief Medical Officer
$50K 2026-04-01